May 6 2024Purdue University Qi "Tony" Zhou, a researcher in Purdue University's College of Pharmacy has received a $2.4 million grant from the National Institutes of Health to fight lung infections that have established a resistance to antimicrobial drugs.
With the latest NIH grant, Zhou has now received six federal grants totaling $10 million, including three NIH R01 grants in the past eight years to support the inhalation therapeutics research. Thomas Sors, director of scientific strategy and relations, Purdue Institute of Inflammation, Immunology and Infectious Disease
"This makes lung infections caused by resistant bacteria extremely difficult to treat, reflected by the fact that lung infections are the fourth leading cause of death in the world," Zhou said. Next development steps Preliminary animal studies showed superior bacterial killing capability and reduced toxicity of the new inhalation medicines.
Source: Education Headlines (educationheadlines.net)
Antimicrobial Resistance Bacteria Cystic Fibrosis Drug Discovery Drugs Fibrosis Immunology Inflammation Lungs Pneumonia Research Technology Therapeutics Ventilator
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CRASH_NET_F1 - 🏆 100. / 51 Read more »
Source: SkySports - 🏆 58. / 63 Read more »
Source: Motorsport - 🏆 11. / 86 Read more »
Source: CRASH_NET_F1 - 🏆 100. / 51 Read more »
Source: The Athletic UK - 🏆 123. / 51 Read more »
Source: The Athletic UK - 🏆 123. / 51 Read more »